VDR Agonists Increase Sensitivity of MCF-7 and BT-474 Breast Cancer Cells to 5 FU

Dagmara Kłopotowska(Ludwik Hirszfeld Institute of Immunology and Experimental Therapy), Janusz Matuszyk(Ludwik Hirszfeld Institute of Immunology and Experimental Therapy)
Anticancer Research
February 1, 2020
Cited by 7


Related Papers